Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations

Metabolism: Clinical and Experimental

Volumn 59, Issue 3, 2010, Pages 424-429

  Yun, Ji Eun ^a   Kimm, Heejin ^a   Jo, Jaeseong ^a   Jee, Sun Ha ^a  

^a Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADULT; BODY MASS INDEX; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERTENSION; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; ODDS RATIO; REPUBLIC OF KOREA; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 76349110535     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.08.012     Document Type: Article

References (35)

1. Reaven G.M., and Laws A. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetolgia 37 (1994) 948-952
2. Chien K.L., Hsu H.C., Sung F.C., Su T.C., Chen M.F., and Lee Y.T. Metabolic syndrome as a risk factor for coronary heart disease and stroke: an 11-year prospective cohort in Taiwan community. Atherosclerosis 194 (2007) 214-221
3. Galassi A., Reynolds K., and He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119 (2006) 812-819
4. Ninomiya T., Kubo M., Doi Y., Yonemoto K., Tanizaki Y., Rahman M., et al. Impact of metabolic syndrome on the development of cardiovascular disease in a general Japanese population: the Hisayama study. Stroke 38 (2007) 2063-2069
5. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., Haffner S.M., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
6. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., and Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994) 425-432
7. Tritos N.A., and Mantzoros C.S. Leptin: its role in obesity and beyond. Diabetologia 40 (1997) 1371-1379
8. Maffei M., Halaas J., Ravussin E., Pratley R.E., Lee G.H., Zhang Y., et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1 (1995) 1155-1161
9. Caro J.F., Kolaczynski J.W., Nyce M.R., et al. Decreased cerebrospinal fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348 (1996) 159-161
10. Considine R.V., Sinha M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334 (1996) 292-295
11. Galletti F., Barbato A., Versiero M., Iacone R., Russo O., Barba G., et al. Circulating leptin levels predict the development of metabolic syndrome in middle-aged men: an 8-year follow-up study. J Hypertens 25 (2007) 1671-1677
12. Ingelsson E., Larson M.G., Yin X., Wang T.J., Meigs J.B., Lipinska I., et al. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. J Clin Endocrinol Metab 93 (2008) 3149-3157
13. Moreno L.A., Pineda I., Rodríguez G., Fleta J., Giner A., Juste M.G., et al. Leptin and metabolic syndrome in obese and non-obese children. Horm Metab Res 34 (2002) 394-399
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
15. Tan C.E., Ma S., Wai D., Chew S.K., and Tai E.S. Can we apply the national cholesterol education program adult treatment panel definition of the metabolic syndrome to Asians. Diabetes Care 27 (2004) 1182-1186
16. Masuzaki H., Ogawa Y., Isse N., Satoh N., Okazaki T., Shigemoto M., et al. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes 44 (1995) 855-858
17. Van Harmelen V., Reynisdottir S., Eriksson P., Thörne A., Hoffstedt J., Lönnqvist F., et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47 (1998) 913-917
18. Minocci A., Savia G., Lucantoni R., Berselli M.E., Tagliaferri M., Calò G., et al. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Int J Obes Relat Metab Disord 24 (2000) 1139-1144
19. Frederich R.C., Hamann A., Anderson S., Löllmann B., Lowell B.B., and Flier J.S. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1 (1995) 1311-1314
20. Söderberg S., Ahrén B., Jansson J.H., Johnson O., Hallmans G., Asplund K., et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 246 (1999) 409-418
21. Söderberg S., Ahrén B., Stegmayr B., Johnson O., Wiklund P.G., Weinehall L., et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 30 (1999) 328-337
22. Söderberg S., Stegmayr B., Stenlund H., Sjöström L.G., Agren A., Johansson L., et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256 (2004) 128-136
23. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
24. Haluzík M., Fiedler J., Nedvídková J., and Ceska R. Serum leptin levels in patients with hyperlipidemias. Nutrition 16 (2000) 429-433
25. Al-Shoumer K.A., Anyaoku V., Richmond W., and Johnston D.G. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol (Oxf) 47 (1997) 153-159
26. Rainwater D.L., Comuzzie A.G., VandeBerg J.L., Mahaney M.C., and Blangero J. Serum leptin levels are independently correlated with two measures of HDL. Atherosclerosis 132 (1997) 237-243
27. Chapman I.M., Wittert G.A., and Norman R.J. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Clin Endocrinol (Oxf) 46 (1997) 175-181
28. Leyva F., Godsland I.F., Ghatei M., Proudler A.J., Aldis S., Walton C., et al. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 18 (1998) 928-933
29. Rosenbaum M., and Leibel R.L. Pathophysiology of childhood obesity. Adv Pediatr 35 (1988) 73-137
30. Rosenbaum M., and Leibel R.L. The role of leptin in human physiology. N Engl J Med 341 (1999) 879-884
31. Comizio R., Pietrobelli A., Tan Y.X., Wang Z., Withers R.T., Heymsfield S.B., et al. Total body lipid and triglyceride response to energy deficit: relevance to body composition models. Am J Physiol 274 5 Pt 1 (1998) E860-E866
32. Ukkola O., and Kesäniemi Y.A. Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. Metabolism 56 (2007) 1221-1227
33. Kennedy A., Gettys T.W., Watson P., Wallace P., Ganaway E., Pan Q., et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 82 (1997) 1293-1300
34. Geer E.B., and Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6 Suppl 1 (2009) 60-75
35. Patel S.B., Reams G.P., Spear R.M., Freeman R.H., and Villarreal D. Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease. Curr Hypertens Rep 10 (2008) 131-137